Transcend Capital Advisors’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History

Transcend Capital Advisors’s Portfolio RETA Stock Details RETA Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell
2023 Q2	$306K	Hold
2023 Q1	$273K	Buy
2021 Q4	–	Sell
2021 Q3	$485K	Buy
2021 Q2	–	Sell
2021 Q1	$564K	Buy
2020 Q4	$668K	Buy